GI

Girish Ichharam Gajare

Active Director Director DIN 00077592
DIN 00077592 First appointment Mar 2001 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Mar 2001
Shareholding value •••• Premium profile

About Girish Ichharam Gajare

Data last updated:

Girish Ichharam Gajare is a Director at Ganpati Diagnostic And Research Centre Private Limited (since 2019), Director at Siddhivinayak Critical Care Centre Private Limited (since 2001) and Director at Siddhivinayak Agro & Trade Private Limited (since 2007). The companies operate in Healthcare and Animal Husbandry. The 2 current companies with reported revenue have a combined latest revenue of ₹4.92 Cr; the largest is Ganpati Diagnostic And Research Centre Private Limited at ₹4.40 Cr (FY 2026). Earlier, Girish Ichharam Gajare was a Director at Niramay Neonatal And Pediatric Intensive Care Unit Private Limited (2010–2017).

DIN 00077592
Primary Designation Director
Industry Healthcare
First Appointment 05 Mar 2001
Oldest Company Age 28 yrs
Largest company Ganpati Diagnostic And Research Centre Private Limited · ₹4.40 Cr (FY 2026)
Combined revenue ₹4.92 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Feb 20191998₹4.40 Cr (FY 2026)Active
Director05 Mar 20012001₹52.4 Lakh (FY 2025)Active
Director23 Nov 20072007Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20102005₹2.45 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Siddhivinayak Agro & Trade Private Limited
Ganpati Diagnostic And Research Centre Private Limited
Siddhivinayak Critical Care Centre Private Limited
Niramay Neonatal And Pediatric Intensive Care Unit Private Limited
Premium access

Shareholding and investment profile for Girish Ichharam Gajare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish Ichharam Gajare

Girish Ichharam Gajare currently holds 3 directorships: Ganpati Diagnostic And Research Centre Private Limited (Director, since 22 Feb 2019, revenue ₹4.40 Cr (FY 2026)); Siddhivinayak Critical Care Centre Private Limited (Director, since 05 Mar 2001, revenue ₹52.4 Lakh (FY 2025)); Siddhivinayak Agro & Trade Private Limited (Director, since 23 Nov 2007).

Girish Ichharam Gajare was first appointed on 05 Mar 2001 as Director at Siddhivinayak Critical Care Centre Private Limited. The most recent appointment on record is 22 Feb 2019 at Ganpati Diagnostic And Research Centre Private Limited.

The 2 current companies of Girish Ichharam Gajare that report revenue have a combined latest revenue of ₹4.92 Cr: Ganpati Diagnostic And Research Centre Private Limited ₹4.40 Cr (FY 2026); Siddhivinayak Critical Care Centre Private Limited ₹52.4 Lakh (FY 2025).

Girish Ichharam Gajare held 1 earlier board appointment: Niramay Neonatal And Pediatric Intensive Care Unit Private Limited (Director, 13 Feb 2010 to 01 Apr 2017).

The current boards of Girish Ichharam Gajare's companies include Anil Jagannath Khadke (Ganpati Diagnostic And Research Centre Private Limited), Rajendra Namdeo Patil (Ganpati Diagnostic And Research Centre Private Limited), Sanjeev Nilkantha Zambare (Ganpati Diagnostic And Research Centre Private Limited), Shrikant Pitambar Rane (Ganpati Diagnostic And Research Centre Private Limited), Sunil Vasudeo Chaudhari (Ganpati Diagnostic And Research Centre Private Limited), Jyoti Girish Gajare (Siddhivinayak Critical Care Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available